GoHealth 2025 Q3 Earnings Sharp Net Loss Deteriorates 2142.9%

GoHealth (GOCO) reported fiscal 2025 Q3 earnings on Nov 14, 2025, revealing a significant revenue drop and a net loss. The results fell far below expectations, with no guidance provided for future periods.

Revenue

GoHealth’s total revenue plummeted 71.1% year-over-year to $34.19 million, driven by a sharp decline in Medicare Advantage segment performance. Medicare Agency Revenue accounted for $26.29 million, while Commission Revenue totaled $22.17 million. Partner Marketing and Other Revenue contributed $4.12 million, and Total Other Revenue reached $7.29 million, with Other Non-Agency Revenue at $6.89 million. The company’s focus on retention over growth led to reduced Medicare Advantage enrollments, impacting overall revenue.

Earnings/Net Income

The company swung to a net loss of $313.92 million, or $11.80 per share, marking a 2142.9% deterioration from the $15.37 million net income in 2024 Q3. This represents a significant negative shift in profitability, with sustained losses for five consecutive years. The EPS loss reflects severe operational challenges.

Post-Earnings Price Action Review

The stock price of GoHealth experienced a steep decline post-earnings, with a 4.70% drop on the latest trading day, a 25.22% weekly loss, and a 42.78% month-to-date plunge. The market’s reaction underscores investor concerns over the company’s financial health and strategic direction.

CEO Commentary

CEO Vijay Kotte acknowledged challenges including declining Medicare Advantage enrollment and rising healthcare costs. Strategic priorities include reallocating resources to high-margin segments, enhancing digital tools, and maintaining a cautious approach to market stabilization. The leadership remains cautiously optimistic about long-term opportunities despite short-term headwinds.

Guidance

GoHealth did not provide explicit forward-looking guidance, emphasizing cost discipline and strategic realignment. The CEO highlighted confidence in long-term market opportunities but refrained from quantitative targets, focusing instead on qualitative expectations for financial stability.

Additional News

GoHealth secured a $50 million investment from Norwest Equity Partners, signaling external confidence in its strategic pivot. The CEO emphasized intentional market pullback, prioritizing retention and quality over volume. The company also announced a $40 million super priority facility to bolster liquidity, alongside board refreshment to support long-term value creation.